Berita Pasar Saham
Berita keuangan terbaru · Diperbarui Jul 24, 2026
Ripple Menutup Kesepakatan Bank Setiap Minggu: Mengapa Pemegang XRP Tidak Merasakan Manfaatnya
Ripple Is Closing Bank Deals Every Week: Why XRP Holders Aren’t Seeing the Benefit
The panel generally agrees that Ripple's success in institutional adoption and stablecoin (RLUSD) growth does not translate to XRP token …
Raksasa ritel mal menutup toko terakhir di kota penting setelah 26 tahun
Mall retail giant closes final store in key city after 26 years
Despite positive trends like 7% Gap brand growth and 39% digital penetration, the panel is concerned about Athleta's 10% decline …
AMD Baru Mencapai Tertinggi Sepanjang Masa -- Apakah Terlambat untuk Membeli?
AMD Just Hit an All-Time High -- Is it Too Late to Buy?
The panel discusses AMD's record-breaking quarter, with concerns around valuation, supply chain constraints, and demand visibility. The key debate revolves …
Acuta Capital Bertaruh pada Erasca (ERAS) dan Menargetkan Pengobatan Kanker dengan Pembelian 354.575 Saham
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
Apakah Kailera Therapeutics Layak Dibeli Setelah IPO yang Membara?
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
Apakah Saham LegalZoom Layak Dibeli Setelah CEO Membeli 125.000 Saham?
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
Greg Abel Membeli Saham yang Kemungkinan Merupakan Saham Favorit Warren Buffett. Haruskah Anda Membelinya Juga?
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Patient Square Membuat Taruhan Besar pada Nektar Pharmaceuticals (NKTR) Membeli 210.000 Saham
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …
Warren Buffett Telah Mengatakan Ini Selama Bertahun-tahun. 1 ETF Vanguard Menerapkan Nasihat Itu.
Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.
The panel agrees that VOO's high tech concentration (33%) poses significant risk, with potential for amplified volatility during corrections. They …
Ipsen : Data Corabotase Menunjukkan Kemanjuran Cepat dan Tahan Lama pada Garis Kerut Dahi
Ipsen : Corabotase Data Demonstrate Rapid, Durable Efficacy In Glabellar Lines
Ipsen's corabotase shows promising Phase II data with rapid onset and strong 24-week durability versus Dysport, but Phase III results …
Apakah Saham WaterBridge Layak Dibeli Setelah Ranger Investment Meningkatkan Kepemilikannya Sebesar 345.000 Saham?
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
Despite Gemini's 'regulatory moat' argument, the panel consensus is bearish due to WaterBridge's high debt, lack of consistent profitability, and …
Lime Mengajukan IPO -- Beli Saham Ini Sebagai Gantinya
Lime Filed for an IPO -- Buy This Stock Instead
The panel consensus is bearish on Lime's IPO, citing the 'going concern' warning, Lime's debt maturity, and the risk of …